 .         
  

  

  


  .        
    ? !     - ,     .     ,       .    ,      .                ,         .

      ,        ?      .   ?                  ?

      ,        ,    ,           .      ,        ,    .           .

  PDF A4   .





 ,  ,  

 :         



                .     , ,    . ,        ,    ,    ,    ,         ,    .



  ., , , 2021

  ., , 2021

  ., , 2021

  .., , 2021

  ., , 2021

  , , , 2021

 .   , 2021







XXII .      .   .    .   ,         .  ,    .   .         .  30 ,        ,            .     .     ,      .    ,   .     ?    .    ,    .

,    ,     .

  ,     :   ,  ,  ,   ,     .         ,    ,    .      (,    .)       !.

 !   ,       ,        ,     120   .      ,          ,   !      2006     ,     ,      2020     : http://parus.web.ur.ru (http://parus.web.ur.ru/) ( URL: http://bessmertie.ru (http://bessmertie.ru/)).     .    .     ,     .

  ,     ,      !        .       .          ,    ,  ,          ,     ,      .    , ,     100 ,      .      101117 .     ,       .       90-100 ,        .

  , , IT-  , ,   ,   ,   ,     .   [http://slb.expert (http://slb.expert/)]      RLEgroup [https://rlegroup.net/rle_about (https://rlegroup.net/rle_about)]  nestarenieRU [https://nestarenie.ru],        ,      ,            [1].

  RLEgroup   ,                , ,    .

  nestarenieRU   .         ,   ,  ,    ,         .

   ,      ,     .    ,    90-100 ,    .      ,        .

      .      :

1)   RLEGroup              ,   ;

2)   nestarenieRU    10         ,     ,        .

  ,       XXII . ,      .

 


  

      ,       .         ,        .   ,    7080       ,        ,        . ,    ,  .     ,               .

     .    .                   .                 (   ),        ,     . ,  ,      ,     :        ,      .      ,  ,     ,              , ,    ,  ,   .         .    .    .

      ,       .       ,             - .   ,       ,  ,       .    ,                ,          .          ,        .          .

 ,       ,    ,   ,     , -       ,             ,      .

         ,    ,    .               .                     .                   ,              .        ,  .

,          .   ,         ,     .      ,    .           ,                   .       ,        .                 .      ,      .               .   ,       ,    .

 




 1

,     





    ?


 1990 .           .   ,    ,     .       ?     ,   .       ,    .    .        ,      .        . ,         .   ,     .     .      . ,      . ,    ,     ,        ,    .

 ,     ,   .    ?  1990     . ,    ,  ,   ,      .           .       ,    ,   ,      ,      .  ,       ,      .   ,     - ,   30-  ,      ,      ,   . ,       ,    .         .           YouTube  : https://youtu.be/S5kuaV_XJ5s (https://youtu.be/S5kuaV_XJ5s).

 ?    ,     .       .         .   ? ,    .  ,     ?   ?      :  ,     ! ( .   ).     ,   ,     ?    ,             ,       ,  ,  ,  ,        ,      .

 2019   -          :          [1].        ,      ,       ,      ,        .      .  :    ,    ,      [2].        ,       .   ,         .  ,   , ,   .        , ,   ,     ,     [2].

       ,          .  2008    ,  ,  GlaxoSmithKline (.1)  720  , ,     100 , ,   ,    ,    [4, 5].  2010   Pfizer  ,   ,               [2, 6].

    ,       ,       .    ,    ,   (NMN),  NAD+ [2].   Time  ,  NAD+     .  (NAD)   ,      - ,     /  .   ,   NAD+,   ,    ,       5%   1015  [7],     .        NAD+    .              [8, 9],     NAD+ [10, 11].       (   )  ,               [12].   ,      , , ,          35%     .  ,     ,   ,    NAD+,      .   ,      ,   ,      NAD+     NAD+       [13].






.1.   GlaxoSmithKline, , 2  2012 [3]



    ,      .    ,  ,   .     ,       ,  ,      .               :     NMN.

 - academy.sk.ru 4  2013    ,        ,    5-10         [14].

  2016   ,    NCPharm,     ,     ,         ,   ,        ,   -        [15].

     .

         - ໠    2018    RT        [16].

    .    ,   ,   - life.ru 27  2019  [17].

 -   8 2018     :  ,    :          [18].

  ntv.ru 8  2018   ,    :                   150  [19].

 -   31  2020      -5     :    ,         [20].

          ,       ,          10?      -?  ,  ,      2001 ,    ,  1970     15   :      [21].   ,            ,   ,          .             ?         ,        ,      ,      .       ,      ,      .       ,         - ?

,      ?     ?




  


          .  .     .    ,       .    .    .      .    ,        .        ,           .   ,    .     ,     !      .     .

   ,     .   2007        ,   ,    ,  405410  [22].   ,        500 .       ,  ,     507  [23, 24].    ,     ,   [25].   ,    ,    .       ,  ,   .      ,    [26].        ,             [27].  ,               .       ,    .   ,       ,       .     ,      .     ,   (     ),            .          [28, 29].

     .    ,   , ,       ,      .    ,   ,    .    ,         ,    .

        ,     .  -             [30].       ,      [31].        1977       ,          ,      .         [32].         ,       1989  [33],    .      2011  [34].  ,     ,          [35]. ,           ,      [36].      ,   2015  [37].  ,         ,         .         ,    [38].

  ,     , ,    ,        [39].  , ,    -3     .       -3?       2018      -3      - ,    ,       ,   -3      [40],         ,       -3 .

   ?     ,     [41],     .      ,     ,    ,     .




  


     .  .   D    (100 000  1   3 )        [42]          [43].   D


 1000 /       2259  (4575 )                25- D >12 /    [44].  ,    D    ,   ,   D .   ?     .     D,    .     .         ,   ,      .    .






.2.      .    



          (.2)?      , ,     .    ,     . ,      ,   ,    .   .   ,       .          .          ,     - .       D   .  ,   D      100%,     .        .          .  ,   ,        ,        [45].    D   ?    D  ,     ?




   


   ,       (.3)   ,         .           [46].  ,    ,   28  585    , ,        [47].     ,  .   ,      ,       [48].       ,       ,    ,    .      .






.3.  



 XXI .    .        .      ,      .    -  ,      .     , ,      D.

    ,    .    ,     .          .        ,      - ,       .        , ,   ,    ,            D    ,       D    [49].            .  ,     -    D,   ,            ,       :       D ( 1000 /),      D (400-1000 /),     ().      ,    .            D,      ,       .    .     2019           D3       [50].




  


       .        ,     ,          .  ,      ,  ,   .        .         .      ,    ,       .    .

15  1744           .         ,         .  1955       500.         ,    ,      ,       .

,    XVIIXVIII        .     ,        ,  , ,     ,   [51].     ,          XIX   XX .             .  ,     .    ,        C [52],    [53].

      ,     ,            -   .  1747        HMS Salisbury       .       .   ,    ,        (.4) [5557].






.4.  



    , ,   ,        ,          .             ,   ,   .     ,   ,   -    .   ,     ,     .               ,      . ,   ,        ,        .       ,     [58].        ,  ?          ,  ,   ,      [59].

     ,             ?   2020    ,      .       ,        ,        .   ,    ,     .     ,       ,      [60]. ,      ,         .            ,           ,            [61].







COVID-19      ,   SARS-CoV-2 [62].          Solidarity,                [63].                 ,    .      ,     .

       COVID-19   ,    »   .          ,    ». : ,            COVID-19.        ?      ?

  .     COVID-19       65  ( 5-14%) [64, 65],     -  ( 10,5%),   ( 7,3%),    ( 6,3%),   ( 6%),   ( 5,6%), ,    ,   [66].                COVID-19 .

   ,       COVID-19       ,    B.             ,             .            ,            ?  .   , , ,   »   ,     .

        ,   ,      »      .                     .      .            .

   ?      ,   ( ) .     .            .

       ,    ,             ,    .      [67]          30  80  (.5).          30 . ,    51    ,    50 .    ,    ,      ,     .       , ,  ,  ,   ,       ,           .   ,         ?  !        ,       .

    ,          .    ,       ,    , ,     .






.5.  .          2003 






   


 1704    60        ,    ,  .     ,    1700  1725 ,    .        ,            ,      .  1817       .       ,    .      [69].  ,      ,   ,         ,    [70],     .

 ,        (.6),        XX ,    ,       ,     [41].






.6.     ,   1721 .         ,   .      (1716 )    ,           [68]



31 1943              ,         .     .       .       ,   ,       .

                       .        ,        .       .       ,     ,     .    ,           .          . .  [71].  : 55  95 ,  , ,      85   ( )   .              .       1943 .   ,     ,  ,   ,     ,      [72].

  1943     .    ,  ,    : ,   ,  ,   ().             :       .     ,   ,  ,    ,       ,               .  ,  ,    .        1348 : 668    680  .

   ,           1944 .  29 ,    ,       .   ,              : ,     .   :      ,       [73].          , , ,   ,   ,            ,   .     .            .

 COVID-19.     2020    COVID-19     ,       .    ,  ,         ,  COVID-19.       2020               COVID-19   .

,           ,         COVID-19     ,     ,    . ,  ,     ,  .   ,    ,   ,       .   , ,     ,      COVID-19,        . ,    ,     .           .

     /,    + ,     ,    ,   ,             [74].  ,   ,   COVID-19,      - ,     ,  /,    +        -  -    [75].

    COVID-19   ()     ?      100%   ,          ,  .          .   ( )       ,   ,           .

    ,    ,        ,      [76]. ,  ,       .  .   Family Health International   2002   ,  ,       ,    ,        [77].




  


      ()  2017  ,     D (25-(OH))        , ,    ,   1-  2-  [78, 79].        D (25-(OH))     4056 / [79].    ,      ( 40 /)  D (25-(OH))      ,      - ,   D (25-(OH))     40 /.    -  ,          [80, 81].        D (25-(OH))  ,    20 /.

  .       ,     .    , ,    ,       ,      . ,              ,  ,     [82].               .   ,            .    [83].             .              .    [84].       .  ,      ,         .    [85].           .              ,      .    [86].

 ?          D (25-(OH))    40 /.        - ,             D,    2016       [87].          ,          ,           ,        .

,     D (25-(OH))    20 /     [80, 81],       - ,           .






.7.   [88].   https://commons.wikimedia.org/wiki/File: GG_2018.2.jpg



     1990    (.7)    [89].             .         ,        [90].     , , ,           [91,92].

    -    ,      ,    .          .

,     , . ,    ,        .  -   ,   -,       .    ,     ( ) .        - .      .     ,        - .           - ,    ,   .

  ?  .      ,     ,     2,5   [93].           ,    20102015  [94].   ,    ,   ,     [95],            .         (   ),     [9698].     2019     -    ,           [99, 100].     ,       ,     .        ,               .    2019       -  [101].       ,   -,        ,        [102].




  


          (FDA)            .        .          1332%      ,     I     [103].

 ,          ,      . ,           I      .     .






.8.           (CFDA)



     (Free radio Asia),   ,           (.8),             80% ,         [104].   ,              ,          - .             -   ,    ,   2013    Science [105, 106].

          [106] (www.medach.pro (http://www.medach.pro/)          ).  ,             : Artificial Cells Nanomedicine and Biotechnology (Taylor & Francis)  76 , Journal of Cellular Biochemistry (Wiley)  57 , Biomedicine & Pharmacotherapy (Elsevier)  45 , Cellular Physiology and Biochemistry (Karger)  26 , Experimental and Molecular Pathology (Elsevier)  26 , Journal of Cellular Physiology (Wiley)  21 .    ,   ,  2016 ,       20182020 .   :   ,                .    .

 ,   ,   ,   .    ,              2020  [107],        ,        .        . ,       ,      ,     .  2005          .     454       ,          .  ,          ,  ,  250            .   .

    ,             ,      .       ,    .     .    .   ,          ,    .      ,         . ,            .     ,   (  )    ,       .      ,            .      ,      ,         .                .   ,      ,      ,   ,      .         ,     -.           .

       ,        ,    .   ,         - .

    ,   Heel      .  Hl         1936  [108].

     - ,          .

,  2016        Heel       ,   .       ,    ,    .                .  ,   ,           [109].  2017 ,         Springer,        .                [110].   .

     -       ,      .            1  6    .      . ,    .     ,      .

      ,     ?    ,       ,   ,    .      :             . , ,               .       :           . ,                .  , ,  ,   ,        ,      .          1  6      .     ,       .

, ,  ,       -       ,     ?   .   ,   2012   :  ,        ,    ,          , ,           . ,        ,      [111].

        .    :         酻.   ,        ,         .            .  ,       ,    ,           .              .       .      ,       ,        -       ,    ,      .

   , ,    ,       ,     .         ,    ,      ,  - . ,        - .    ,     3--3--- (), ,     .           1 111 407  ,        ,             ,      [112].        ,    ,      .          40%,   .              1 111 407  [112].

  ,    - ,   2019      ,             ,    .    19 114    ,    100     ()  .

       .   ,           .  ,           [113].   !

 ,    ,     ,     ,      .        .     ,         .




 


   10 .      .     ,       .   ,         ,    ,     ,    .     ,         .      ,     .    .      .

     ,           .      .           , , ,   ,      .

   ,  ,   :    [114].               () [115].          (  ),     ,    .  .      ?   ?

        ,        ,   .       ,    .      ,        . ,       .           3000 ,           ,     ,      [116],              ,       [117].           ,        .

        ,         ,      .      -:   .  .           . ,  ,            .    (  ),       ,        [118].




    ,  ?


   (.9)  ,      ,        6,4 [119, 120].






.9.   [121]



          .       -0,6  +12C.  ,           272 ,    -  .     ( 502)    392  120  [122, 123].  20102013            28  . ,      ( 5)  272512   ( ,  ,       1).         (,      150 ),    -       [122].

   -,    .      .        ,   Arctica islandica   ,       .    ,  ,     ,       ,   .       .     ,    ,     .       33C,   ,    - [124].

,   -            ,     ,     .   ,     ,               ?

- ,     ,    .  , .         ,     ,     .  ?

 .    ,      . ,          2026C.        3031C.         ,       ,              [125].               ,  .  ,               .

,  ,     .           ,   . ,   ?   ,  ? ,    ,  .             .     ,   .        -    (,    ).     .                 -   . ,     ,          - ,   .             .    ,        ,   .      .         35C   6 .          .     1518C   20 .   ,    ,    ,    .        .         .    ,  ,     ( 140/90  . .),     :    12 ,     25 ,     12     65 .

          . ,           2  ,   ,    2025  . .     ,               - ,      .     ,     -        [126].

  ,   .     90     ,        ,         ,      .

          , ,    ,       .        ,    ,     ( )   UCP2,   ,     [127].      ,       .        20%,         12%.       ,     ,           [128].      ,        .    ,         ,     ,       .             [125],                [129131].          ,     .       ,   .    ,              .           .

             ,      .          ,           , , ,   .         .         :    ,      .

       ,           :              .                .    70%                     [132].  , ?

 ,    ?   , ,             ,       ?     11412,    TeGenero,      ,     ,      .           [133, 134].  2006      I   11412          [133].              (    ) [135].   ,        ,       .     ,   ,        .              [136].

 ,  10-2474,     Bial-Portela & Ca. S. A.,      .  2016      I        ,      ,  ,         [137140].  10-2474       ,       .      10-2474,     ,    2017    [141].              ,          [142, 143],        [144].

,      I     .  ,          II  III       ?       . -        .        -   ,       8,7% [103].

   III           .      .

 IV      ,                           .  ,       ,         .

, ,   ,     2016                 .     ,           .     2018                       .      12             [145].          ,     ,  ,        [146].

           ,    ? ,    ,        ,   100%,    .  ,   ,    ,     .




 


1.Sinclair D., LaPlante M.D., Delphia C. Lifespan: why we age-and why we dont have to. New York: Atria Books, 2019. www.worldcat.org/title/lifespan-why-we-age-and-why-we-dont-have-to/oclc/1088652276 ( : 17.12.2020).

2.Elton C. Whos to Blame When a Violent Offender Gets Bailed Out? Bostonmagazine, Wellness: 10/29/2019. www.bostonmagazine.com/health/2019/10/29/david-sinclair ( : 17.12.2020).

3. 1. ( ) URL: https://www.shutterstock.ru.

4.John C., McBride R. Updated: gsk moves to shutter Sirtris Cambridge office, integrate R&D. Mar 12, 2013. www.fiercebiotech.com/r-d/updated-gsk-moves-to-shutter-sirtris-cambridge-office-integrate-r-d ( : 17.12.2020).

5.Ledford H. GSK absorbs controversial longevity company. News blog.13 Mar 2013. http://blogs.nature.com/news/2013/03/gsk-absorbs-controversial-longevity-company.html ( : 17.12.2020).

6.Pacholec M., Bleasdale J.E., Chrunyk B. et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010 Mar 12;285(11):8340-51. doi: 10.1074/jbc.M109.088682. www.ncbi.nlm.nih.gov/pubmed/20061378 ( : 17.12.2020).

7.Zhang H., Ryu D., Wu Y. et al. NAD


 repletion improves mitochondrial and stem cell function and enhances life span in mice. Science. 2016 Jun 17;352(6292):1436-43. doi: 10.1126/science.aaf2693. www.ncbi.nlm.nih.gov/pubmed/27127236 ( : 17.12.2020).

8.Dollerup O.L., Christensen B., Svart M. et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018 Aug 1;108(2):343353. doi: 10.1093/ajcn/ nqy132. www.ncbi.nlm.nih.gov/pubmed/29992272 ( : 17.12.2020).

9.Dollerup O.L., Trammell S.A.J., Hartmann B. et al. Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity. J Clin Endocrinol Metab. 2019 Nov 1;104(11):57035714. doi: 10.1210/jc.2019-01081. www.ncbi.nlm.nih.gov/pubmed/31390002 ( : 17.12.2020).

10.Dellinger R.W., Santos S.R., Morris M. et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD + levels in humans safely and sustainably: arandomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis. 2017 Nov 24;3:17. doi: 10.1038/s41514-017-0016-9. www.ncbi.nlm.nih.gov/pubmed/29184669 ( : 17.12.2020).

11.Dellinger R.W., Santos S.R., Morris M. et al. Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD + levels in humans safely and sustainably: arandomized, double-blind, placebo-controlled study. NPJ Aging Mech Dis. 2018 Aug 20;4:8. doi: 10.1038/s41514-018-0027-1. www.ncbi.nlm.nih.gov/pubmed/30155270 ( : 17.12.2020).

12.Dollerup O.L., Chubanava S., Agerholm M. et al. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men. J Physiol. 2020 Feb;598(4):731754. doi: 10.1113/JP278752. www.ncbi.nlm.nih.gov/pubmed/31710095 ( : 17.12.2020).

13.Kourtzidis I.A., Stoupas A.T., Gioris I.S. et al. The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats. J Int Soc Sports Nutr. 2016 Aug 2; 13:32. doi: 10.1186/s12970-016-0143-x. www.ncbi.nlm.nih.gov/pubmed/27489522 ( : 17.12.2020).

14. .   . ( ) URL: https://old.sk.ru/news/b/press/archive/2013/04/04/tabletka-ot-starosti.aspx ( : 17.12.2020).

15.    ,   .  . 07.11.2016. ( ) URL: https://ria.ru/20161107/1480812008.html ( : 17.12.2020).

16. . ,      :      ,    .   . 11  2018. ( ) URL: https://russian.rt.com/science/article/490572-lekarstvo-ot-starosti-uchenye ( : 17.12.2020).

17.    .    . LIFE. 27  2019. ( ) URL: https://life.ru/p/1250863 ( : 17.12.2020).

18. .  ,    :         .  , 8  2018. ( ) URL: www.kp.ru/daily/26792/3826751 ( : 17.12.2020).

19.  150:           .  . ( ) URL: www.ntv.ru/novosti/2071483 ( : 17.12.2020).

20. . -5     :    ,        .  , 31  2020. ( ) URL: www.kp.ru/daily/27074.7/4146348 ( : 17.12.2020).

21.Akerlof G.A. 15  The market for lemons: quality uncertainty and the market mechanism. ( ) URL: https://doi.org/10.1016/B978-0-12-214850-7.50022-X ( : 17.12.2020).

22.Munro D., Blier P.U. The extreme longevity of Arctica islandica is associated with increased peroxidation resistance in mitochondrial membranes. Aging Cell. 2012 Oct;11(5):845-55. doi: 10.1111/j.14749726.2012.00847.x. www.ncbi.nlm.nih.gov/pubmed/22708840 ( : 17.12.2020).

23.Butler, P.G., Wanamaker, A.D., Scourse J.D.et al. Variability of marine climate on the North Icelandic Shelf in a 1357-year proxy archive based on growth increments in the bivalve Arctica islandica: Palaeogeography, Palaeoclimatology, Palaeoecology. 2013 March 1; 373(1):141151. https://doi.org/10.1016/j.palaeo.2012.01.016 ( : 17.12.2020).

24.Brix L. New record: Worlds oldest animal is 507 years old. ( ) URL: https://sciencenordic.com/ageing-denmark-geochemistry/new-record-worlds-oldest-animal-is-507-years-old/1392743 ( : 17.12.2020).

25.Sahu S., Dattani A., Aboobaker A.A. Secrets from immortal worms: What can we learn about biological ageing from the planarian model system? Semin Cell Dev Biol. 2017 Oct;70:108121. DOI: 10.1016/j.semcdb. 2017.08.028. doi: 10.1016/j. semcdb.2017.08.028. www.ncbi.nlm.nih.gov/pubmed/28818620 ( : 17.12.2020).

26.Sal E. The power of regeneration and the stem-cell kingdom: freshwater planarians (Platyhelminthes). Bioessays. 2006 May;28(5):546-59. doi: 10.1002/ bies.20416. www.ncbi.nlm.nih.gov/pubmed/16615086 ( : 17.12.2020).

27.Kenk R. Freshwater planarians (Turbellaria) of North America. Washington,1972. https://doi.org/10.5962/bhl.title.4020www.biodiversitylibrary.org/bibliography/4020#/ summary ( : 17.12.2020).

28.Tan T.C., Rahman R., Jaber-Hijazi F. et al. Telomere maintenance and telomerase activity are differentially regulated in asexual and sexual worms. Proc Natl Acad Sci USA. 2012 Mar 13;109(11):4209-14. doi: 10.1073/pnas.1118885109. www.ncbi.nlm.nih.gov/pubmed/22371573 ( : 17.12.2020).

29.Salo E., Abril J.F., Adell T. et al. Planarian regeneration: achievements and future directions after 20 years of research. Int J Dev Biol. 2009;53(8-10):1317-27. doi: 10.1387/ijdb.072414es. www.ncbi.nlm.nih.gov/pubmed/19247944 ( : 17.12.2020).

30.Emily D.Want to Make a Lie Seem True? Say It Again. And Again. And Again. Welcome to the illusory truth effect, a glitch in the human psyche that equates repetition with truth. WIRED. Business 02.11.2017. www.wired.com/2017/02/dont-believe-lies-just-people-repeat ( : 17.12.2020).

31.Stafford T. How liars create the illusion of truth. BBC FUTURE [Neurohacks. Psychology]. ( ) URL: www.bbc.com/future/article/20161026-how-liars-create-the-illusion-of-truth ( : 17.12.2020).

32.Hasher L., Goldstein D., Toppino T. Frequency and the Conference of referential validity. Journal of verbal learning and verbal behavior, 16, 107112 (1977). ( ) URL: https://web.archive.org/web/20160515062305/http://www.psych.utoronto.ca/users/hasher/PDF/Frequency%20and%20the%20conference%20Hasher%20et%20al%201977.pdf ( : 17.12.2020).

33.Arkes H.R., Hackett C., Boehm L. The Generality of the Relation betweenFamiliarity and Judged Validity. Journal of Behavioral Decision Making. 1989:2(81):94. ( ) URL: www.researchgate.net/profile/Hal_Arkes/publication/229937605_The_generality_of_the_relation_between_familiarity_and_judged_validity/links/5a58a81faca2725b78077ef9/The-generality-of-the-relation-between-familiarity-and-judged-validity.pdf ( : 17.12.2020).

34.Ozubko J.D., Fugelsang J. (2011). Remembering makes evidence compelling: Retrieval from memory can give rise to the illusion of truth. Journal of Experimental Psychology: Learning, Memory, and Cognition, 37(1), 270276. https://doi.org/10.1037/a0021323 https://doi.apa.org/doiLanding?doi=10.1037%2Fa0021323 ( : 17.12.2020).

35.The Truth Effect and Other Processing Fluency Miracles. ( ) URL: https://scienceblogs.com/mixingmemory/2007/09/18/the-truth-effect-and-other-pro ( : 18.12.2020).

36.Galvin G. The Globalization of Fake News. ( ) URL: https://web.archive.org/web/20171230212523/https://www.usnews.com/news/best-countries/articles/2017-12-30/how-fake-news-charges-spread-around-the-globe( : 18.12.2020).

37.Fazio L.K., Brashier N.M. et al. Knowledge Does Not Protect Against Illusory Truth. Journal of Experimental Psychology: General 2015;144(5): 993-1002. ( ) URL: https://web.archive.org/web/20160514233138/https://www.apa.org/pubs/journals/features/xge-0000098.pdf ( : 18.12.2020).

38.Hitler A. Mein Kampf. ( ) URL: http://greatwar.nl/books/meinkampf/meinkampf.pdf ( : 18.12.2020).

39.Pringle H., Field P. Brand Immortality: How Brands Can Live Long and Prosper. Kogan Page, 2008. ( ) URL: https://zh.b-ok2.org/ book/654409/1e9571FirefoxHTML-308046B0AF4A39CB/Shell/Open/Command ( : 18.12.2020).

40.Abdelhamid A.S., Brown T.J., Brainard J.S. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease: Cochrane Database of Systematic Reviews Intervention. ( ) URL: www.cochranelibrary.com/cdsr/ doi/10.1002/14651858.CD003177.pub3/full ( : 18.12.2020).

41.Hrobjartsson A., Emanuelsson F., Thomsen A.S.S. Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. International Journal of Epidemiology 2014 Au-gust;43(4):12721283; doi: 10.1093/ije/dyu115. https://academic.oup.com/ije/ article/43/4/1272/2952051 ( : 28.02.2020).

42.Manaseki-Holland S., Maroof Z., Bruce J. et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: arandomised controlled superiority trial. Lancet. 2012 Apr 14;379(9824):1419-27. doi: 10.1016/S0140-6736(11)61650-4. www.ncbi.nlm.nih.gov/pubmed/22494826 ( : 18.12.2020).

43.Somnath S.H., Biswal N., Chandrasekaran V. et al. Therapeutic effect of vitamin D in acute lower respiratory infection. Clin Nutr ESPEN. 2017 Aug;20:2428. doi: 10.1016/j.clnesp.2017.02.003. www.ncbi.nlm.nih.gov/pubmed/29072165 ( : 18.12.2020).

44.Rees J.R., Hendricks K., Barry E.L. et al. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis. 2013 Nov;57(10):1384-92. doi: 10.1093/cid/cit549. www.ncbi.nlm.nih.gov/pubmed/24014734 ( : 18.12.2020).

45.Cohen S., Doyle W.J., Alper C.M. et al. Sleep habits and susceptibility to the common cold. Arch Intern Med. 2009 Jan 12;169(1):62-7. doi: 10.1001/ archinternmed.2008.505. www.ncbi.nlm.nih.gov/pubmed/19139325 ( : 18.12.2020).

46.The History Of Herodotus, Book 1, 74. ( ) URL: https:// www.gutenberg.org/files/2707/2707-h/2707-h.htm#link2H_4_0004. [The Project Gutenberg (www.gutenberg.org)] ( : 28.02.2021).

47.Le Conte D. Eclipse Quotations  Part IV. ( ) URL: www. mreclipse.com/Special/quotes1.html ( : 18.12.2020).

48.Querejeta M. On the Eclipse of Thales, Cycles and Probabilities. Culture and Cosmos 2011;15(1): 3-32. ( ) URL: https://arxiv.org/ftp/ arxiv/papers/1307/1307.2095.pdf : https://ui.adsabs.harvard.edu/ abs/2013arXiv1307.2095Q/abstract ( : 18.12.2020).

49.Finamor D.C., Sinigaglia-Coimbra R., Neves L.C. et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013 Jan 1;5(1):222-34. doi: 10.4161/ derm.24808 www.ncbi.nlm.nih.gov/pubmed/24494059 ( : 18.12.2020).

50.Reynolds K.A., Pithadia D.J., Lee E.B., Wu J.J. Treatments for inverse psoriasis: asystematic review. J Dermatolog Treat. 2020 Dec;31(8):786793. doi: 10.1080/09546634.2019.1620912. www.ncbi.nlm.nih.gov/pubmed/31100992 ( : 18.12.2020).

51.Price C. The Age of Scurvy: Distillations, August 14, 2017. ( ) URL: www.sciencehistory.org/distillations/magazine/the-age-of-scurvy ( : 18.12.2020).

52.Scurvy. National Center for Advancing Translational Sciences. ( ) URL: https://rarediseases.info.nih.gov/diseases/10406/scurvy ( : 18.12.2020).

53.Anil Agarwal, Abbas Shaharyar, Anubrat Kumar et al. Scurvy in pediatric age group  A disease often forgotten? J Clin Orthop Trauma. 2015 Jun;6(2):101-7. doi: 10.1016/j.jcot.2014.12.003. www.ncbi.nlm.nih.gov/pubmed/25983516 ( : 18.12.2020).

54.  [] ( ) URL: https:// www.shutterstock.ru.

55.Lind J. A treatise of the scurvy: in three parts, containing an inquiry into the nature, causes, and cure, of that disease, together with a critical and chronological view of what has been published on the subject. [An extract from James Linds 1753 Treatise of the scurvy]. Bulletin of the World Health Organization: the International Journal of Public Health 2004;82(10):793796. https://apps.who.int/iris/handle/10665/72991 https:// apps.who.int/iris/bitstream/handle/10665/72991/bulletin_2004_82%2810%29_793-796. pdf?sequence=1&isAllowed=y ( : 20.12.2020).

56.Hugh Baron J.H. Sailors scurvy before and after James Lind  a reassessment. Nutr Rev. 2009 Jun;67(6):315-32. doi: 10.1111/j.17534887.2009.00205.x. www.ncbi. nlm.nih.gov/pubmed/19519673 ( : 20.12.2020).

57.Lind J. A treatise of the scurvy: in three parts. Containing an inquiry into the nature, causes, and cure, of that disease. Together with a critical and chronological view of what has been published on the subject. The third edition, enlarged and improved. London. 1772. ( ) URL: https://archive.org/details/ b30511902/page/n5/mode/2up; https://archive.org/details/b30511902 ( : 20.12.2020).

58.Stubbs B.J. Captain Cooks beer: the antiscorbutic use of malt and beer in late 18th century sea voyages. Asia Pac J Clin Nutr. 2003; 12(2):129-37. www.ncbi.nlm.nih. gov/pubmed/12810402 ( : 20.12.2020).

59.Tonelli M. R. In defense of expert opinion. Acad Med. 1999 Nov;74(11):1187-92. doi: 10.1097/00001888-199911000-00010. www.ncbi.nlm.nih.gov/pubmed/10587679 ( : 20.12.2020).

60.Caulfield T., Rachul C. Supported by science?: what canadian naturopaths advertise to the public. Allergy Asthma Clin Immunol. 2011 Sep 15;7(1):14. doi: 10.1186/1710-1492-7-14. www.ncbi.nlm.nih.gov/pubmed/21920039 ( : 20.12.2020).

61. .      .   05.02.2017. ( ) URL: www.kommersant.ru/doc/3211619 ( : 20.12.2020).

62. ,   (COVID-19),   . ( ) URL: www.who.int/ru/emergencies/ diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it ( : 20.12.2020).

63.WHO. Coronavirus disease (COVID-19) pandemic. ( ) URL: www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments ( : 20.12.2020).

64.IL POST. Cosa dice il nuovo rapporto dellIstituto Superiore di Sanita sul coronavirus. ( ) URL: www.ilpost.it/2020/03/11/rapporto-istituto-superiore-sanita-coronavirus-italia ( : 20.12.2020).

65.The updates on COVID-19 in Korea as of 13: Press Release. ( ) URL: www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view &list_no=366549&tag=&nPage=1 ( : 20.12.2020).

66.Yang J., Zheng Y., Gou X. et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: asystematic review and meta-analysis. Int J Infect Dis. 2020 May; 94:9195. doi: 10.1016/j.ijid.2020.03.017. www.ncbi.nlm.nih.gov/ pubmed/32173574 ( : 20.12.2020).

67.Arias E. United States Life Tables, 2003. Natiohal Vital Statistcs Reports. 2006 April 19;54(14). Report revised as of March 28, 2007. ( ) URL: www.cdc. gov/nchs/data/nvsr/nvsr54/nvsr54_14.pdf ( : 20.12.2020).

68. 6. ( ) URL: https://www.shutterstock.ru.

69.Dubourg G. The violin: some account of that leading instrument and its most eminent professors, from its earliest date to the present time: with hints to amateurs, anecdotes, etc. London, 1852. Addeddate 2007-04-19 18:36:21. ( ) URL: https://archive.org/details/violinsomeaccoun00duboiala ( : 20.12.2020).

70.Fritz C., Curtin J., Poitevineau J., Tao F.C. Listener evaluations of new and Old Italian violins. Proc Natl Acad Sci U S A. 2017 May 23;114(21):53955400. doi: 10.1073/pnas.1619443114. www.ncbi.nlm.nih.gov/pubmed/28484030 ( : 20.12.2020).

71.Hopkins W.A. IV. Biological Properties: Extended Trial in the Common Cold. Published: November 20, 1943. DOI: https://doi.org/10.1016/S0140-6736(00)88179-9www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)88179-9/fulltext ( : 21.12.2020).

72.Stuart-Harris C.H., Francis A.E., Stansfeld J.M. (1943). Patulin in the common cold. Lancet 2:684. ( ) URL: www.jameslindlibrary.org/stuart-harris-ch-francis-ae-stansfeld-jm-1943 ( : 21.12.2020).




  .


   .

   ,     (https://www.litres.ru/pages/biblio_book/?art=66553382)  .

      Visa, MasterCard, Maestro,    ,   ,     ,  PayPal, WebMoney, ., QIWI ,       .


